AptoGEL · A 3D Platform for Mesenchymal Stem Cell Homing
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2020-09-01 → 2022-08-31
- EU contribution
- €191,149
- Participants
- 1
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
AptoGEL: A 3D Platform for Mesenchymal Stem Cell Homing
It is estimated that about 0.5% of the world’s population will require an articular cartilage (AC) intervention at some point in their life. Current treatment options for chondral lesions are only marginally successful, and if left untreated, lead to osteoarthritic (OA) joint disease, one of the major sources of disability world-wide. Many of the common surgical approaches to treat cartilage lesions such as microfracture (MF), are dependent on the efficient migration of cells from the underlying subchondral bone (SB) to ensure successful regeneration of the tissue. However, the extent of cell migration and hence the clinical outcome, is highly variable. To overcome this critical limitation, a scaffold is proposed which uses two key mechanisms to induce stem cell migration. Firstly, the scaffold is composed of granular hydrogels, whose void space naturally facilitates the endogenous migration of mesenchymal stem cells (MSCs). Secondly, some microgels are modified with sulfate groups, to allow the retention of positively charged growth factors (GFs) (e.g., TGFB3 and PDGF-BB). Therefore, hyaluronic acid (HA) was triple-modified with methacrylate groups, transglutaminase (TG)-sensitive peptides and sulfate groups to produce AptoGEL, a new and exciting material with key properties needed for chondral regeneration. We believe this advanced, yet biocompatible material, provides an ideal 3D environment for promoting cell migration and differentiation leading to a fully functional chondral repair. In conclusion, in this project we were able to transform bulk hydrogels where the cells cannot penetrate into a granular system with cell guidance capabilities. The results demonstrated that our strategy can be easily extrapolated to other tissues and, the most important, the whole system can retain different GFs cocktails depending on the need.
Data: CORDIS, © European Union
Project objective
It is estimated that about 0.5% of the world’s population will require an articular cartilage (AC) intervention at some point in their life. Current treatment options for osteochondral (OC) lesions are only marginally successful, and if left untreated, lead to osteoarthritic (OA) joint disease, one of the major sources of disability world-wide. Many of the common surgical approaches to treat cartilage lesions like, microfracture (MF), are dependent on the efficient migration of cells from the underlying subchondral bone (SB) to ensure successful regeneration of the tissue. However, the extent of cell migration and hence the clinical outcome, is highly variable. To overcome this critical limitation, a scaffold is proposed which uses two key mechanisms to induce stem cell migration. Firstly, the scaffold is composed of macroporous annealed particle (MAP) hydrogels, whose void space naturally facilitates endogenous the migration of mesenchymal stem cells (MSCs). Secondly, the microgels are modified with a specific aptamer, Apt19S, which has been shown to have high affinity to MSCs. Specifically in this project; hyaluronic acid (HA) will be triple-modified with methacrylate groups, transglutaminase (TG)-sensitive peptides and the Apt19S aptamer to produce AptoGEL, a new and exciting material with key properties needed for OC regeneration. We hypothesize this advanced, yet biocompatible material, will provide an ideal 3D environment for promoting cell migration and differentiation leading to a more fully functional OC repair
Original text from CORDIS.
Participants
- EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH · ZuerichCoordinatorSwitzerland
Links
- View on CORDIS
- DOI: 10.3030/885797
- https://biofabrication.ethz.ch/research/biomaterials0/microgel-microstrands.html
Data: CORDIS, © European Union
